INS and Hypoglycemia: Obviously, it is essential to T2D patients to achieve and maintain the glycemic control, preferentially without adding basal insulin therapy, because it was related to increased number of patients experiencing hypoglycemia during 1 year of follow-up of basal insulin therapy [27].